Publication:
Characteristics and survival results of peritoneal dialysis patients suffering from COVID-19 in Turkey: A multicenter national study

dc.contributor.authorGürsu, Meltem
dc.contributor.authorÖztürk, Savaş
dc.contributor.authorArıcı, Mustafa
dc.contributor.authorŞahin, İdris
dc.contributor.authorGökçay Bek, Sibel
dc.contributor.authorYılmaz, Mürvet
dc.contributor.authorKoyuncu, Sümeyra
dc.contributor.authorKarahisar Sıralı, Semahat
dc.contributor.authorUral, Zeynep
dc.contributor.authorDursun, Belda
dc.contributor.authorYüksel, Enver
dc.contributor.authorUzun, Sami
dc.contributor.authorSipahi, Savaş
dc.contributor.authorAhbap, Elbis
dc.contributor.authorArtan, Ayşe Serra
dc.contributor.authorAltunören, Orçun
dc.contributor.authorTunca, Onur
dc.contributor.authorAyar, Yavuz
dc.contributor.authorGök-Oğuz, Ebru
dc.contributor.authorYılmaz, Zülfükar
dc.contributor.authorKahvecioğlu, Serdar
dc.contributor.authorAşıcıoğlu, Ebru
dc.contributor.authorOruç, Ayşegül
dc.contributor.authorAltıparmak, Mehmet Rıza
dc.contributor.authorAydın, Zeki
dc.contributor.authorHuddam, Bülent
dc.contributor.authorDolarslan, Mürşide Esra
dc.contributor.authorAzak, Alper
dc.contributor.authorBakirdoğen, Serkan
dc.contributor.authorYalçın, Ahmet Uğur
dc.contributor.authorKaradağ, Serhat
dc.contributor.authorUlu, Memnune Sena
dc.contributor.authorGüngör, Özkan
dc.contributor.authorArı Bakir, Elif
dc.contributor.authorOdabas, Ali Riza
dc.contributor.authorSeyahi, Nurhan
dc.contributor.authorYıldız, Alaattin
dc.contributor.authorAteş, Kenan
dc.contributor.buuauthorORUÇ, AYŞEGÜL
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı.
dc.contributor.orcid0000-0002-0342-9692
dc.contributor.researcheridAAH-4002-2021
dc.date.accessioned2024-10-16T06:03:00Z
dc.date.available2024-10-16T06:03:00Z
dc.date.issued2022-09-13
dc.description.abstractBackground: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome.Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded.Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis.Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.
dc.identifier.doi10.1159/000526909
dc.identifier.endpage615
dc.identifier.issn1420-4096
dc.identifier.issue10
dc.identifier.startpage605
dc.identifier.urihttps://doi.org/10.1159/000526909
dc.identifier.urihttps://karger.com/kbr/article/47/10/605/824500/Characteristics-and-Survival-Results-of-Peritoneal
dc.identifier.urihttps://hdl.handle.net/11452/46498
dc.identifier.volume47
dc.identifier.wos000856925300001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherKarger
dc.relation.journalKidney & Blood Pressure Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMortality
dc.subjectPhysiology
dc.subjectUrology & nephrology
dc.subjectCardiovascular system & cardiology
dc.titleCharacteristics and survival results of peritoneal dialysis patients suffering from COVID-19 in Turkey: A multicenter national study
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationbd386ce4-0765-45b7-9a09-c10b5eca584a
relation.isAuthorOfPublication.latestForDiscoverybd386ce4-0765-45b7-9a09-c10b5eca584a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oruc_vd_2022.pdf
Size:
336.27 KB
Format:
Adobe Portable Document Format

Collections